IC

Ikarian Capital Portfolio holdings

AUM $302M
1-Year Est. Return 65.21%
This Quarter Est. Return
1 Year Est. Return
+65.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$241M
AUM Growth
-$68K
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
106
New
Increased
Reduced
Closed

Top Buys

1
+$10.6M
2
+$9.86M
3
+$8.27M
4
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$7.32M
5
APLS icon
Apellis Pharmaceuticals
APLS
+$6.6M

Top Sells

1
+$17.5M
2
+$10.2M
3
+$5.94M
4
CLDX icon
Celldex Therapeutics
CLDX
+$5.81M
5
ETNB icon
89bio
ETNB
+$5.78M

Sector Composition

1 Healthcare 97.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$1.08M 0.24%
+360,569
52
$1.05M 0.24%
200,000
53
$1.04M 0.23%
254,945
54
$1.01M 0.23%
139,565
55
$1.01M 0.23%
+162,527
56
$1.01M 0.23%
472,625
+50,000
57
$999K 0.23%
+292,599
58
$990K 0.22%
+174,714
59
$969K 0.22%
650,000
60
$932K 0.21%
15,582
61
$774K 0.18%
+48,170
62
$747K 0.17%
17,805
-50,000
63
$719K 0.16%
43,156
-160,000
64
$711K 0.16%
6,874
65
$677K 0.15%
62,766
66
$627K 0.14%
12,662
67
$585K 0.13%
188,664
68
$526K 0.12%
179,552
+130,521
69
$524K 0.12%
221,830
70
$479K 0.11%
260,087
71
$476K 0.11%
20,511
72
$462K 0.1%
156,203
73
$342K 0.08%
59,177
-19,171
74
$304K 0.07%
11,638
75
$293K 0.07%
+10,000
1 2
3
4 5